Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print GERD patient satisfaction hinges on medication type and physician bedside manner

GERD patient satisfaction hinges on medication type and physician bedside manner

August 03, 2009

Patient satisfaction with their medications and the quality of interactions with their doctor reflect the success of gastroesophageal reflux disease (GERD) therapy, according to a new study in Clinical Gastroenterology and Hepatology, the official journal of the American Gastroenterological Association (AGA) Institute.

"Although patient satisfaction is a complex issue, improvements in recognition of GERD can improve management of the disease as well as patient satisfaction with their care and treatment," said Peter Bytzer, MD, PhD, of Copenhagen University and lead author of the study. "Patient satisfaction can be influenced by a number of factors including treatment regimen, general level of well-being, the 'bedside manner' of the physician, the patient's expectations and the quality of patient/physician communication."




The researchers found that patients who were given prescriptions for proton pump inhibitors (PPIs) tended to be more satisfied than those given H2-receptor antagonists. Partial responders were likely to be more dissatisfied than patients whose symptoms were fully resolved. In addition, a decrease in health-related quality of life (HRQoL) was associated with greater dissatisfaction. In fact, decreasing HRQoL was correlated with decreasing satisfaction with medical care in general. Patients were more likely to be satisfied if they were taken seriously by their physician and if their symptoms were investigated. They were also more likely to be satisfied if the patient/physician consultation was interactive.

"Of the various factors influencing patient satisfaction, the quality of patient/physician communication is probably the most amenable to improvement. This can be done by using validated questionnaires to help physicians identify more effectively which symptoms patients have, and the impact of these symptoms on the patient's well-being," added Dr. Bytzer.

Researchers reviewed the possible reasons why patients were dissatisfied with the way their disease is managed. Studies published between 1970 and 2007 were identified from PubMed, EMBASE and the author's existing database; 11 studies were found to be appropriate for use in this review. A key strength of this review was the fact that the searches identified a wide range of studies with varying methodologies.

Typically characterized by frequent or troublesome heartburn and/or acid regurgitation, GERD is a chronic, painful condition that impairs HRQoL. GERD may result in disturbed sleep, reduced productivity at work and impaired daily activities. Despite the efficacy of PPIs as therapeutics for patients with GERD, a number of studies have shown that a proportion of patients with the disease are not satisfied with their treatment. In fact, population-based surveys show that at least one-third of individuals taking medication for GERD are not satisfied with their treatment. This is particularly true for those taking over-the-counter medicines to relieve symptoms.

American Gastroenterological Association



Related Gastroesophageal Reflux Disease Current Events and Gastroesophageal Reflux Disease News Articles Gastroesophageal Reflux Disease Current Events and Gastroesophageal Reflux Disease News RSS Gastroesophageal Reflux Disease Current Events and Gastroesophageal Reflux Disease News RSS
Reflux esophagitis due to immune reaction, not acute acid burn, UT Southwestern researchers report
Contrary to current thinking, a condition called gastroesophageal reflux disease (GERD) might not develop as a direct result of acidic digestive juices burning the esophagus, UT Southwestern Medical Center researchers have found in an animal study.

Barrett's esophagus patients have same survival rates as general population
New Mayo Clinic research has found that survival rates of patients with Barrett's esophagus, which can be a precursor for esophageal cancer, are no different than the survival rates for the general population.

GERD negatively impacts sleep quality, results in considerable economic burden
There has been much debate about the relationship between gastroesophageal reflux disease (GERD) and sleep.

NEJM study finds radiofrequency ablation can reverse Barrett's esophagus, reduce cancer risk
Patients who have gastroesophageal reflux disease (GERD) for a prolonged period have an increased risk of developing Barrett's esophagus, a pre-cancerous condition where the tissue lining the esophagus becomes damaged by stomach acid and transformed into something like the inside of the stomach.

Obesity predicts inadequate bowel prep at colonoscopy
Obesity is an independent predictor of inadequate bowel preparation at colonoscopy, and the presence of additional risk factors further increases the likelihood of a poorly cleansed colon.

Use of acid-suppressive medications associated with increased risk of hospital-acquired pneumonia
Hospitalized patients who receive acid-suppressive medications such as a proton-pump inhibitor have a 30 percent increased odds of developing pneumonia while in the hospital.

Study examines reliability of clinical and pathological diagnoses of Barrett's esophagus
In a review of more than 2,000 patients coded for Barrett's esophagus, electronic diagnosis overestimated the prevalence of the disease according to researchers in California.

Chronic diarrhea unresponsive to conventional medication: Are you taking lansoprazole?
Lansoprazole is a proton pump inhibitor which powerfully suppresses gastric acid production and is widely prescribed for chronic use in gastroesophageal reflux disease.

Is esomeprazole the best choice for reflux esophagitis patients?
In patients with gastroesophageal reflux disease (GERD), esomeprazole, has demonstrated pharmacological and clinical benefits beyond those seen with the other proton pump inhibitors( PPIs ).

Alcohol types and socioeconomic status are associated with Barrett's esophagus risk
Although the relationship between alcohol and esophageal squamous cell carcinoma is well established, studies investigating the association between alcohol intake and reflux esophagitis (RE), Barrett's esophagus (BE) and esophageal adenocarcinoma (EAC) have reported inconsistent findings.
More Gastroesophageal Reflux Disease Current Events and Gastroesophageal Reflux Disease News Articles
Gastroesophageal Reflux Disease: Principles of Disease, Diagnosis, and Treatment

Gastroesophageal Reflux Disease: Principles of Disease, Diagnosis, and Treatment
by Frank Alexander Granderath (Editor), Thomas Kamolz (Editor), Rudolph Pointner (Editor)

Gastroesophageal reflux disease (GERD) is one of the most common disorders with an increasing prevalence and incidence in the last two decades. This book, edited by two experienced surgeons and a clinical psychologist in cooperation with numerous worldwide leading experts, presents clinically relevant information for gastroenterologists, internists, surgeons, residents and also nurses, who frequently care for GERD patients. Focusing on different treatment concepts – medical, endoscopic as well as surgical – the chapters include the basics of symptomatology and epidemiology, pathophysiology, GERD among different age groups, complications and its treatment, hiatal hernia or H. pylori and GERD, NERD and functional heartburn, diagnostic procedures and also presurgical examination. In...

Gastroesophageal Reflux Disease (Gastroenterology and Hepatology)

Gastroesophageal Reflux Disease (Gastroenterology and Hepatology)
by Orlando (Author)

Tulane Univ., New Orleans, LA. Discusses the epidemiology, pathogenesis, diagnosis, complications, and management of gastroesophageal reflux disease (GERD). Concentrates on the various disorders sharing common pathogenesis of GERD to include disorders of the esophagus, oropharynx, larynx, and upper respiratory tract.

Nocturnal GERD (Home Use)

Nocturnal GERD (Home Use)

GERD (Gastroesophageal Reflux Disease, commonly known as "acid reflux") is hard to miss, or ignore - especially if you're one of the 15-20 million Americans who suffer from this chronic, potentially dangerous condition every day. But did you know that you can have GERD and not be aware of it? Nocturnal GERD occurs when you're asleep - you might have no symptoms at all during the day - and may be tied to other sleep disorders. Learn the warning signs on this eye-opening episode of "Healthy Body, Healthy Mind".

This product is manufactured on demand using DVD-R recordable media. Amazon.com's standard return policy will apply.



Olympian Labs Enzyme Blend Ol-767 (Pack of 2)

Olympian Labs Enzyme Blend Ol-767 (Pack of 2)
by Olympian Labs



Gastroesophageal Reflux Disease In Children

Gastroesophageal Reflux Disease In Children
Lifeline Audio Books (Primary Contributor)



Chronic Cough (NCME Video 747)

Chronic Cough (NCME Video 747)
Also With: Network For Continuing Medical Education (Primary Contributor), Richard S. Irwin (Primary Contributor)

In the United States, cough is the single most common complaint of adult patients to their primary care physicians. Chronic cough, a persistently troublesome cough lasting at least three weeks, is most often due to postnasal drip syndrome, asthma, or gastroesophageal reflux disease. Other causes include chronic bronchitis from cigarette smoking, bronchiectasis, or ACE inhibitor therapy. Once diagnosed, targeted Read more... In the United States, cough is the single most common complaint of adult patients to their primary care physicians. Chronic cough - a persistently troublesome cough lasting at least three weeks - is most often due to postnasal drip syndrome, asthma, or gastroesophageal reflux disease. Other causes include chronic bronchitis from cigarette smoking, bronchiectasis, or...

Gastric Gold Aloe Vera AMP 90 Count Bottle

Gastric Gold Aloe Vera AMP 90 Count Bottle
by Alternative Health Products

Gastric Gold is helpful in reversing and correcting many digestive and gastrointestinal tract disorders and diseases. A.M.P. (Aloe Mucilaginous Polysaccharide) the main ingredient in Gastric Gold purifies the blood, cleanses the liver, restores and protects the digestive tract, while it works to stop the damaging causes of these painful conditions: The Aloe Vera plant has been recognized for many years for its remarkable health-enhancing properties. In the past it was known for external applications for the skin only. Concentrated and stabilized Aloe (AMP) the active ingredient in Gastric Gold, is now widely used to help a variety of conditions in the digestive tract. The digestive tract is designed to ensure nutrients from food are absorbed into the blood stream while dispensing with...

Gastroesophageal Reflux Disease: A Clinician's Guide, 3rd Ed.

Gastroesophageal Reflux Disease: A Clinician's Guide, 3rd Ed.
by Gary Gitnick (Author)

Provides the clinician with information about causation, complications, natural course, and management of GERD. The efficacy, safety, and suggested regimens of pharmacologic therapies are discussed. Data on the relationship between GERD and asthma are presented. The clinical presentation of GERD patients with chronic cough and laryngitis is discussed in detail.

Gastroesophageal Reflux Disease and Airway Disease (Lung Biology in Health and Disease)

Gastroesophageal Reflux Disease and Airway Disease (Lung Biology in Health and Disease)
by Stein (Author)

Univ. of South Florida, Tampa. Analyzes practical, in-office approaches to diagnosis and treatment in all age groups. Clarifies when to consider surgical treatment, details warning signs of GERD, recommends pediatric dosing schedules, and more. For allergists, pediatricians, internists, gastroenterologists, and other clinicians.

Olympian Labs 5 Htp Plus, 100mg (Pack of 2)

Olympian Labs 5 Htp Plus, 100mg (Pack of 2)
by Olympian Labs

5-HTP, also known as 5-hydroxytryptophan, is the direct precursor to the neurotransmitter serotonin. Low levels of serotonin are associated with sleep problems, depression, anxiety, compulsive eating disorders, restless leg syndrome, migraines, fibromyalgia and low pain threshold. Serotonin is an important initiator of sleep. 5-HTP has been shown to decrease the time required to get to sleep and to decrease the number of awakening. It also increases REM sleep and deep sleep. By increasing the brain’s concentration of serotonin, an antidepressant effect is created. 5-HTP works by increasing the amount of serotonin manufactured in the brain. Although systematically administered serotonin does not readily enter the brain, its direct precursor, 5-HTP does penetrate the blood - brain...

© 2009 BrightSurf.com